Sale!

Understanding Leukemias Lymphomas and Myelomas 2nd Edition by Tariq Mughal, John M Goldman, Sabena Mughal ISBN 0203340949 9781841844091

Original price was: $50.00.Current price is: $35.00.

Understanding Leukemias Lymphomas and Myelomas Second Edition Tariq Mughal Digital Instant Download

Author(s): Tariq Mughal, Tariq I Mughal, John M Goldman, John M. Goldman, Sabena Mughal, Sabena T Mughal
ISBN(s): 9781841844091, 0203340949
Edition: 1
File Details: PDF, 6.40 MB
Year: 2005
Language: english
SKU: EB-1368410 Category: Tags: , , , ,

Understanding Leukemias Lymphomas and Myelomas 2nd Edition by Tariq Mughal, John M Goldman, Sabena Mughal – Ebook PDF Instant Download/Delivery: 0203340949, 9781841844091
Full download Understanding Leukemias Lymphomas and Myelomas 2nd Edition after payment

Product details:

ISBN 10: 0203340949 
ISBN 13: 9781841844091
Author: Tariq Mughal, John M Goldman, Sabena Mughal

A practical and highly illustrated guide to the hematologic cancers, Understanding Leukemias, Lymphomas and Myelomas is an invaluable primer for everyone involved with these conditions, from specialists in training to interested patients. Using straightforward terminology and extensive color figures to describe and illustrate the current procedures involved in diagnosis and treatment, this is a ready source of up to date information on these common conditions.

Understanding Leukemias Lymphomas and Myelomas 2nd Table of contents:

Part I: General Principles and Diagnostics

  • Chapter 1: Normal Hematopoiesis and the Pathophysiology of Malignancy

    • Anatomy and function of the hematopoietic system.

    • Genetic and molecular basis of hematological cancers.

  • Chapter 2: Diagnostic Evaluation and Classification

    • Bone marrow biopsy and aspiration.

    • Blood smear analysis.

    • Flow cytometry, cytogenetics, and molecular testing.

  • Chapter 3: Principles of Treatment

    • Chemotherapy, targeted therapy, and immunotherapy.

    • Stem cell transplantation (autologous and allogeneic).

    • Role of radiation therapy.

Part II: Leukemias

  • Chapter 4: Acute Myeloid Leukemia (AML)

    • Epidemiology and risk factors.

    • Clinical presentation and diagnosis.

    • Treatment strategies and prognosis.

  • Chapter 5: Acute Lymphoblastic Leukemia (ALL)

    • Clinical features and subtypes.

    • Pediatric and adult ALL.

    • Modern treatment approaches.

  • Chapter 6: Chronic Myeloid Leukemia (CML)

    • The role of the Philadelphia chromosome (BCR-ABL1).

    • Tyrosine kinase inhibitors (TKIs) and their management.

    • Monitoring and treatment-free remission.

  • Chapter 7: Chronic Lymphocytic Leukemia (CLL)

    • Clinical course and staging.

    • Watch and wait approach vs. active treatment.

    • New agents and targeted therapies.

  • Chapter 8: Myelodysplastic Syndromes (MDS)

    • Classification and risk stratification.

    • Treatment options from supportive care to transplantation.

  • Chapter 9: Myeloproliferative Neoplasms (MPNs)

    • Polycythemia vera, essential thrombocythemia, and myelofibrosis.

    • JAK2 mutations and targeted therapies.

Part III: Lymphomas

  • Chapter 10: Hodgkin Lymphoma

    • Histology and subtypes.

    • Staging and risk factors.

    • Modern chemotherapy regimens and long-term effects.

  • Chapter 11: Non-Hodgkin Lymphoma (NHL): B-Cell Subtypes

    • Diffuse Large B-Cell Lymphoma (DLBCL).

    • Follicular Lymphoma.

    • Mantle Cell Lymphoma.

    • Other B-cell lymphomas.

  • Chapter 12: Non-Hodgkin Lymphoma (NHL): T-Cell and NK-Cell Subtypes

    • Peripheral T-Cell Lymphoma.

    • Mycosis fungoides and Sézary syndrome.

  • Chapter 13: Cutaneous Lymphomas

    • Diagnosis and management of skin lymphomas.

Part IV: Myelomas and Other Plasma Cell Disorders

  • Chapter 14: Multiple Myeloma

    • Pathogenesis and clinical features.

    • Diagnostic criteria and staging systems.

    • Current treatment landscape: proteasome inhibitors, immunomodulatory drugs, and antibodies.

  • Chapter 15: Monoclonal Gammopathy of Undetermined Significance (MGUS)

    • Risk of progression.

    • Monitoring and management.

  • Chapter 16: Systemic Amyloidosis

    • Types and organ involvement.

    • Diagnosis and treatment.

Part V: Supportive Care and Emerging Therapies

  • Chapter 17: Management of Complications

    • Infections, neutropenic fever, and transfusions.

    • Tumor lysis syndrome and other oncologic emergencies.

  • Chapter 18: Cellular and Gene Therapies

    • CAR-T cell therapy.

    • Bispecific antibodies.

    • Future directions in cellular therapy.

  • Chapter 19: The Role of the Patient and Caregiver

    • Patient education and empowerment.

    • Psychosocial support and quality of life.

People also search for Understanding Leukemias Lymphomas and Myelomas 2nd:

understanding leukemias lymphomas
    
understanding leukemias lymphomas and myelomas
    
difference between lymphomas and leukemias
    
are lymphomas hard
    
understanding leukemia
    
understanding lymphoma

 

Tags: Tariq Mughal, John M Goldman, Sabena Mughal, Leukemias, Lymphomas